Winner

The winner of the second Kowsar International Hepatology award was Prof. Dr. Med. Michael Roggendorf, Professor of Hepatology at the University Of Essen, Germany.

Poster

Booklet

INTERNATIONAL SPEAKERS:

  • Prof. F. Blaine Hollinger (USA) – Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, USA
  • Prof. Samir Haffar (Syria) – Syrian Society of Gastroenterology, Syria
  • Prof. Peter Karayiannis (UK) – Department of Medicine, Imperial College London, London, UK
  • Prof. Daniel Lavanchi (Switzerland) – WHO, Geneva, Switzerland
  • Prof. Mario Rizzetto (Italy) – Department of Gastroenterology, University of Torino, Torino, Italy
  • Prof. Michael Roggendorf (Germany) – Institute for Virology, University of Duisburg-Essen, Essen, Germany
  • Prof. Muhammad Umar (Pakistan) – Rawalpindi Medical College, Rawalpindi, Pakistan
  • Dr. Nazir Ibrahim (Syrea)   – Syrian Society of Gastroenterology, Syria
  • Prof. Aamir Ghafoor Khan (Pakistan) – Hayatabad Medical Complex, Peshawar Pakistan
  • Prof. Alferedo Alberti (Italy) – Department of Histology Microbiology and Medical Biotechnologies, University of Padova, Italy

Time Table

First Day

Date/Time Lecturer Title
8:00-8:20 Opening Ceremony
8:20-8:40 Registration at Secretariat office
8:40-9:00 Prof. Yalda Ethics and Medicine
SESSION 1
————
Chairmen:
Prof. MR Zali
Prof. M Roggendorf
HBV Infection: Epidemiology & Prevention
9:00-9:15 Prof. Mohammad Reza Zali Epidemiology of Hepatitis B in Iran
9:15-9:30 Dr. Mohammad Mehdi Gooya Prevention Strategies in Control of HBV in Iran
9:30-9:45 Prof. Kamran Bagheri Lankarani Accelerated Vaccination for HBV
9:45-10:00 Prof. Michael Roggendorf Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck
10:00-10:20 >>>International KOWSAR award<<<<
10:20-10:40 …: Break :…
SESSION 2
————
Chairmen:
Prof. R Malekzadeh
Prof. P Karayiannis
Chronic Hepatitis B: Diagnosis & Treatment
10:40-11:05 Prof. Peter Karayiannis Molecular Targets and Immunological Pathways in Chronic HBV Infection
11:05-11:20 Prof. Reza Malekzadeh When to Treat Subjects with Minimally Active Chronic HBV?
11:20-11:35 Prof. Mehdi Saberi-Firoozi Update in Antiviral Therapy in Cirrhosis due to HBV Infection
11:35-12:00 Prof. F.Blaine Hollinger Occult Hepatitis B in Blood Donors: Transmission Concerns
12:00-12:15 Dr. Pouryasin Molecular Resistance of HBV infected patients, Iranian experiences
12:15-12:25 Q&A
12:25-13:25 …: Prayer, Lunch :…
SESSION 3
————
Chairmen:
Prof. MR Zali
Prof. KB Lankarani
Prof. M Umar
Chronic Hepatitis C: Diagnosis & Treatment
13:25-13:50 Prof. Muhammad Umar Treatment of Hepatitis C Non-Responders and Relapsers
13:50-14:05 Prof. Houri Rezvan Diagnosis and Interpretation of HCV Tests
14:05-14:20 Prof. SM Alavian Iranian Experience with Pegasys Therapy in HCV Infection in Hemophilia and Thalassemia: A National Study
14:20-14:35 Dr. Keyvani Updates of Molecular Diagnosis of HCV
14:35-14:50 Dr. Saeid Ghavami Role of Autophagy in HCV and HBV: Possible new therapeutic approach
14:50-15:05 …: Break :…
15:05-15:30 Prof. Aamir Ghafoor Khan Shorter Course of Treatment for HCV Genotype 3
15:30-15:45 Dr. Samir Haffar Hepatitis C before and after Renal Transplantation
15:45-16:00 Q&A

Second Day

Date/Time Lecturer Title
SESSION 1
————
Chairman:
Prof. AG Khan
Prof. D Lavanchi
HCV Infection: Epidemiology & Prevention
8:00-8:25 Prof. Daniel Lavanchi The global Epidemiology of Hepatitis C
8:25-8:50 Prof. Muhammad Umar Burden, Mode of Transmission and Treatment Responses of Hepatitis C in Pakistan
8:50-9:15 Dr. Azzam Kayasseh Hepatitis C in UAE
9:15-9:30 Dr. M Naghipour Epidemiology of Hepatitis C Infection in Iran and the Region: Lessons Should be Learned
9:30-9:45 Dr. Sedigheh Amini Kafi-abad Blood Safety
9:45-9:55 Q & A
9:55-10:30 …: Break :…
SESSION 2
————
Chairman:
Prof. NE Daryani
Dr. N Ibrahim
Management of Chronic Hepatitis B Infection
10:30-10:45 Dr. Behnava Therapy of HBV with Pegasys-Systematic review
10:45-11:10 Dr. Nazir Ibrahim Beta and Gamma Interferons in Chronic Hepatitis B Patients
11:10-11:30 Dr. Seyed-Mohammad Jazayeri Evolution of Genotype D HBV Infection in the World: What is our Experience?
11:25-11:40 Dr. Ashraf Mohamadkhani Virologic and Host Aspects of Hepatitis B Virus Genome Diversity upon Basal Core Promoter Region
11:40-11:55 Dr. Alavi Moghadam Iranian Intarnational Study in Interferon Experiences
11:55-12:10 Dr. Siavash Mansouri Applications of UES in Liver Disease
12:10-12:25 Q&A
12:25-13:25 …: Prayer & Lunch :…
SESSION 3
————
Chairman:
Prof. KB Lankarani
Prof. NE Daryani
HBV infection (A-Z)
13:30-13:45 Dr. Mitra Mahdavi Mazdeh HBV and HCV in Dialysis Patients
13:45-14:00 Prof . Naser Ebrahimi Daryani Drug Induced Liver Injury
14:00-14:15 Dr. Farhad Fathimoghadam The prevalence of Hepatitis B Antigen-positivity in the general population of Mashhad, Iran
14:20-14:40 Dr. Mohammad Hossein Somi Prevention of Hepatitis B in Hemodialysis Patients
14:40-15:00 Prof. Hossein Forootan Treatments and Follow up in Chronic HBV Infection
15:00-15:15 Prof. Mehdi Saberi-Firoozi TREATMENT OF HEPATITIS B VIRUS (HBV)-RELATED LIVER CIRRHOSIS
15:15-15:30 Q & A

Third Day

Date/Time Lecturer Title
SESSION 1
————
Chairman:
Prof. M Rizzetto
Hepatitis D infection
8:00-8:25 Prof. Mario Rizzetto Current epidemiology and clinical features of hepatitis D in Europe and Asia
8:25-8:40 Prof. Seyed Moayed Alavian Epidemiology of HDV in I.R. IRAN
8:40-8:55 Molecular Diagnosis of HDV infection
8:55-9:10 Dr. Keshvari Iranian International Study in HDV Treatment Experiences
9:10-9:25 International Kowsar Award
9:25-9:35 Q&A
9:35-10:00 …: Break :…
SESSION 2
————
Chairman:
Prof. H Forootan
Prof. M Roggendrof
HBV & Autoimmune Hepatitis & MicroRNA
10:00-10:15 Dr. Abolfazl Iranikhah Cyclosporine Use in AIH/Update
10:15-10:30 Dr. Seyyed Mohammad Miri MicroRNAs in Liver Diseases: New Approach in Diagnosis & Treatment
10:30-10:55 Prof. F Blaine Hollinger Will Hepatitis E Virus Become an Emerging Infectious Disease?
10:55-11:20 Prof. Michael Roggendorf Acute hepatitis A is associated with a multispecific CD8+ T cell response in HLA-A2 positive patients
11:20-11:35 Mr. Hadi Karimzadeh Updates on Serological and Molecular Diagnosis Assays for HBV
11:35-11:50 Dr. Farhad Zamani Hepatitis C and Iron/Update
11:50-12:00 Q&A
12:00- 13:00 …: Prayer – Lunch :…
SESSION 3
————
Chairman:
Prof. F Mansour-Ghanaei
Prof. FB Hollinger
HCV in Blood-borne disorders
13:00-13:15 Prof. F Mansour-Ghanaei The Management of Hepatitis C with Normal ALT/Updtae
13:15-13:30 Dr. Azita Azarkeivan Surveillance of New Cases of Hepatitis C in Thalassemia
13:30-13:45 Dr. Fariba Seighali The Latest Treatment Options for Children with Hepatitis C
13:45-14:00 Mrs. Farah Bokharaei Salim Occult Hepatitis C Virus Infection in Iranian Patients with Chronic Liver Disease with Unknown Etiology
14:00-14:15 Q&A
14:15-14:30 …: End of Tehran Part :…

Fourth Day

Date/Time Lecturer Title
SESSION 1
————
Chairman:
Prof. HA Malek Hosseini, Dr. Nik Eghbalian
Liver Transplantation
8:00-8:15 Opening Ceremony
8:15-8:35 Dr. Nik Eghbalian Liver Transplantation: Iran’s Experience
8:35-8:55 Dr. Maryam Moeini Liver Transplantation for Inherited Metabolic Disorders of the Liver
SESSION 2
————
Chairman:
Prof. KB Lankarani
Viral Hepatitis
8:55-9:15 Prof. Mohammad Hadi Imanieh Hepatitis B and C epidemiology in Fars province, 2009
9:15-9:35 Prof. Kamran Bagheri Lankarani Preventive measures in viral hepatitis
9:35-9:55 Prof. Hollinger Management of Hepatitis B: Treatment Options and Resistance Issues
9:55-10:15 Prof. Seyed Moayed Alavian When should hepatitis B not be treated?
10:15-10:45 …: Break :…
SESSION 3
————
Chairman:
Prof. P Karayiannis
Hepatocellular Carcinoma & Other liver diseases
10:45-11:00 Prof. Mahmood Haghighat Autoimmune hepatitis in pediatrics
11:00-11:25 Prof. Peter Karayiannis Expectations for Curative Anti-HBV Treatment and HCC Prevention
11:25-12:00 Prof. Mario Rizzetto The Emerging Challenge of HBV Reactivation with Immunosuppressive Therapies
12:00-12:15 Dr. Mohammad Amin Poorhosseingholi Burden of HCC in I.R. Iran
12:15-12:35 Prof. Hossein Ghanaati Update in RFA for HCC: Iranian Experience
12:35-12:55 Dr. Saeid Ghavami Alpha 1 Antitrypsin Deficiency: Molecular and Cellular Aspects
12:55-13:15 Prof. Aamir Ghafoor Khan Treatment of Hepatitis Patient under Prime Minister Hepatitis Program
13:15-13:30 Conclusion, Q & A

THC3 Board & Committees

THE 3RD INTERNATIONAL TEHRAN HEPATITIS CONGRESS, 6-9 OCTOBER 2010,
TEHRAN & SHIRAZ, IRAN

HELD BY:

  1. Baqiyatallah Research Center for Gastroenterology and Liver Disease, I.R. IRAN
  2. Shiraz University of Medical Sciences, I.R. IRAN
  3. University of Torino, ITALY

THC 3 GOVERNING BOARD:

  1. Prof. Seyed-Moayed Alavian, MD, Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, I.R. IRAN
  2. Prof. Kamran Bagheri-Lankarani, MD; Shiraz University of Medical Sciences, Shiraz, I.R. IRAN
  3. Prof. Mario Rizzetto, University of Torino, ITALY

SCIENTIFIC MANAGER:

  • Prof. Seyed-Moayed Alavian, MD; Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Tehran, I.R. IRAN

EXECUTIVE MANAGER:

  • Hadi Karimzadeh, MSc; Research Associate of Hepatology, Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, I.R. IRAN

INTERNATIONAL AFFAIRS & COMMUNICATION MANAGER:

  • Seyyed Mohammad Miri, MD; Research Associate of Hepatology, Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, I.R. IRAN

COSULTANT(S):

  • Mehrdad Nooranipour, MD; Research Associate of Hepatology, Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, I.R. IRAN
  • Pegah Karimi Elizee, MD; Research Associate of Hepatology, Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, I.R. IRAN

COMMITTEES:

> Scientific Committee:

Adibi P., M.D.
Agah S., M.D.
Aghazadeh R., M.D.
Alavian SM., M.D.
Lankarani KB., M.D.
Ebrahimi Daryani N., M.D.
Forootan H., M.D.
Mansour Ghanaie F., M.D.
Merat Sh., M.D.
Nasiri-Toosi M., M.D.
Somi M., M.D.
Zahedi M., M.D.
Ghamarchehreh ME., M.D.
Behnava B., M.D.
Jazayeri SM., M.D.
Zali MR, M.D.

> Educational Committee:

Hadi Karimzadeh, MSc, Chair
Seyyed Mohammad Miri, MD

> IT Committee:

Shahed Rezamand, Chair
Amir Amini-Bavil-Olyaee

> Executive committee:

Mehdi Ashour, Chair
Hossein Irani

Ehsan Ameri
Farshid Alvandi 

> Secretariat Committee:

Bent-al-Hoda Beyram, Chair
Azam Raufee
Roxana Kabiri Movahed
Ms. Najafi
Ms. Kazemi
Ms. Hosseini
Mr. Mojahed